Search

everythinglearnresearchcommunity

for

Search:↓

Mixing platelet-rich plasma with triamcinolone acetonide can potentially improve hair regrowth in alopecia areata patients.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Vemurafenib can cause scalp issues but can be managed without changing the dose.

These migraine prevention drugs can cause side effects like constipation, hair loss, injection site reactions, fatigue, and sometimes unexpected issues like Raynaud's phenomenon and weight gain.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

Thallium poisoning can cause hair loss, skin rashes, and nerve damage, and can be fatal if not correctly diagnosed and treated.

MENT could be a better option than testosterone for male hormone therapy and birth control because it works well at lower doses and has fewer side effects on the prostate.

Temozolomide improves survival in grade III glioma patients without harming quality of life.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Bevacizumab may worsen hypothyroidism, so thyroid function should be monitored during treatment.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

ARQ-234, a protein designed to treat atopic dermatitis, shows increased effectiveness in early testing.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

GT20029 showed some hair growth improvement, but longer studies are needed for better results.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Rapamycin and anti-EGFR antibody reduce LAM/TSC cell migration and blood vessel growth in the uterus.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Some drugs used to treat inflammation may cause hair loss.

CAR-T therapy offers hope for children with hard-to-treat blood cancers.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Baricitinib was effective in treating alopecia areata in two major trials.

A cat's hyperactivity and hair loss were caused by eating valproic acid but improved after stopping access to the drug.

High doses of Tridax procumbens extract can be toxic, affecting liver and kidneys.